FdaApplication
BLA 761119
Identifiers
- fda_app_no: BLA761119
Properties
| Property | Value |
|---|---|
| applicant_name | Lundbeck Seattle BioPharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2020-02-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VYEPTI | EPTINEZUMAB-JJMR | 100MG/ML | Injection |
1 product